Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
80,900
-1,100 (-1.34%)
At close: Jan 16, 2026
82.41%
Market Cap645.65B
Revenue (ttm)14.90B
Net Income (ttm)-117.78M
Shares Out8.20M
EPS (ttm)-606.21
PE Ration/a
Forward PE225.55
Dividendn/a
Ex-Dividend Daten/a
Volume147,790
Average Volume125,023
Open80,900
Previous Close82,000
Day's Range78,700 - 83,500
52-Week Range35,600 - 101,000
Betan/a
RSI41.43
Earnings DateMar 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.